# Second Genome, Inc. — Form D

Second Genome, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-08-09. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2011-08-09
- Form: D
- Accession: 0001527224-11-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 12
- Date of first sale: 2011-07-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-164097

## Issuer

- Name: Second Genome, Inc.
- CIK: 0001527224
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 1700 OWENS ST, 5TH FL, SAN FRANCISCO, CA, 94158
- Phone: 888-666-0859

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| MICHAEL CARUSI | Director | San Clemente, CA |
| Peter DiLaura | Director | Jersey City, NJ |
| Peter Gardner | Director | Roseville, CA |
| Corey Goodman | Director | Cambridge, MA |
| Jason Lettmann | Director | Edina, MN |
| Matthew Winkler | Director | Menlo Park, CA |
| Peter DiLaura | Executive Officer | Jersey City, NJ |

## More

- [CIK 1527224 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1527224&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001527224-11-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.